2002
DOI: 10.1113/jphysiol.2001.012856
|View full text |Cite
|
Sign up to set email alerts
|

Non‐invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin‐converting enzyme inhibition in diabetic rats

Abstract: A non‐invasive cine magnetic resonance imaging (MRI) technique was developed to allow, for the first time, detection and characterization of chronic changes in myocardial tissue volume and the effects upon these of treatment by the angiotensin‐converting enzyme (ACE) inhibitor captopril in streptozotocin (STZ)‐diabetic male Wistar rats. Animals that had been made diabetic at the ages of 7, 10 and 13 weeks and a captopril‐treated group of animals made diabetic at the age of 7 weeks were scanned. The findings we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
24
1

Year Published

2002
2002
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(28 citation statements)
references
References 90 publications
3
24
1
Order By: Relevance
“…Diabetes impairs this antihypertrophic mechanism and may also compromise the long-term benefits of ACE inhibition on heart size clinically (10) and in experimental animals (7)(8)(9). Other investigators report no loss of antihypertrophic ACE inhibitor efficacy in diabetes (27)(28)(29), but in those studies, the reduction in heart size was secondary to a lowering of blood pressure rather than to a direct antihypertrophic effect as described here. Moreover, in the present study, 8 weeks of streptozotocininduced diabetes per se increased a number of markers of cardiac hypertrophy, including LV protein synthesis and LV ANP and ␤-MHC mRNA expression.…”
Section: Discussionmentioning
confidence: 73%
“…Diabetes impairs this antihypertrophic mechanism and may also compromise the long-term benefits of ACE inhibition on heart size clinically (10) and in experimental animals (7)(8)(9). Other investigators report no loss of antihypertrophic ACE inhibitor efficacy in diabetes (27)(28)(29), but in those studies, the reduction in heart size was secondary to a lowering of blood pressure rather than to a direct antihypertrophic effect as described here. Moreover, in the present study, 8 weeks of streptozotocininduced diabetes per se increased a number of markers of cardiac hypertrophy, including LV protein synthesis and LV ANP and ␤-MHC mRNA expression.…”
Section: Discussionmentioning
confidence: 73%
“…In a previous study, insulin resistance in ApoE(Ϫ/Ϫ) mice was associated with PAH (Hansmann et al, 2007). We found previously PA endothelial dysfunction, a characteristic feature of PAH, in rats with type 1 diabetes, and right ventricular hypertrophy was also reported in streptozotocin-treated rats (Al-Shafei et al, 2002;Lopez-Lopez et al, 2008). Herein, we show that rats treated with streptozotocin share a number of pulmonary vascular abnormalities with animal models and patients with PAH such as down-regulation of BMPR2, COX-2 induction, up-regulation of 5-HT 2A receptors, and vascular hyper-responsiveness to 5-HT in addition to those described previously such as endothelial dysfunction and pulmonary vascular oxidative stress.…”
Section: Discussionmentioning
confidence: 93%
“…dicating that a major component of this phenomenon is not related to acute release of endothelial vasoactive factors. However, differences tended to be smaller in endotheliumdenuded compared with intact vessels, suggesting that endothelial dysfunction (Al-Shafei et al, 2002;Lopez-Lopez et al, 2008) might also play a role. Moreover, it seems to be secondary to the high blood glucose rather than a direct effect of streptozotocin because it was reduced by cotreatment with insulin.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…Increased plasma insulin concentrations are correlated with increased left ventricular mass (39). Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) have been used in studies of dietary effects on cardiac function (2,27). Recent advances in magnetic resonance (MR) technology for high magnetic field systems, including the use of phased array radiofrequency coils, motion compensation techniques, and optimal radiofrequency pulse sequences, now permit investigation of cardiac function and metabolism in greater detail (32).…”
mentioning
confidence: 99%